Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

IRONWOOD PHARMACEUTICALS INC (IRWD)

197 + Investors. Track Smart Money conviction in IRWD. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +29
Streak
2Q ▲
Buyers last Q
62%

Smart Money Signals — IRWD

Based on 191 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added IRWD than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
📊

High ownership — 75% of 3.0Y peak

75% of all-time peak
191 funds currently hold this stock — 75% of the 3.0-year high of 253 funds (reached 2024 Q1). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📉

Outflows — 8% fewer funds vs a year ago

fund count last 6Q
17 fewer hedge funds hold IRWD compared to a year ago (-8% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🟢

More buyers than sellers — 62% buying

121 buying74 selling
Last quarter: 121 funds were net buyers (56 opened a brand new position + 65 added to an existing one). Only 74 were sellers (47 trimmed + 27 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+24 vs last Q)

new funds entering per quarter
Funds opening a new IRWD position: 34 → 18 → 32 → 56. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

59% of holders stayed for 2+ years

■ 59% conviction (2yr+) ■ 20% medium ■ 21% new
112 out of 191 hedge funds have held IRWD for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +4%, value -39%

Value
-39%
Shares
+3%
Last quarter: funds added +4% more shares while total portfolio value only changed -39%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
🚀

Acceleration phase — new buyers rushing in

35 → 34 → 18 → 32 → 56 new funds/Q
New funds entering each quarter: 34 → 18 → 32 → 56. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Deep conviction — 66% of holders stayed 2+ years

■ 66% veterans ■ 9% 1-2yr ■ 25% new
Of 197 current holders: 130 (66%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
🏆

Elite ownership — 40% AUM from top-100 funds

40% from top-100 AUM funds
32 of 191 holders are among the 100 largest funds by AUM, controlling 40% of total institutional value in IRWD. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
2.3
out of 10
Low Exit Risk
Exit risk score 2.3/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — IRWD

In 2025 Q4, 121 hedge funds were net buyers of IRWD (56 opened a new position, 65 added to an existing one), while 74 reduced or exited (47 trimmed, 27 sold completely) — a 62% buyer ratio, indicating clear institutional accumulation. Net buying has persisted for two consecutive quarters, a positive momentum signal. 40% of total institutional value in IRWD is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +29 funds (more new holders than closures). Total institutional holders: 191.

Hedge Fund Ownership: IRWD

How many hedge funds hold IRWD — quarterly history vs. share price
Quarterly hedge fund ownership of IRWD vs. share price

Market Analysis: IRWD

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: IRWD

Healthcare Drug Manufacturers - Specialty & Generic

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

37 top-rated funds 0 high-conviction
Consensus
6.9
/ 10
breadth
×
Elite
0.9
/ 10
conviction
Hedge Fund Positioning: IRWD
2026 Q1 Stats Unlock in 8 days 197 + Investors

Track Smart Money conviction in IRWD. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 197 165 19.39%
13F Shares 166M 160M 3.65%
Total Value $557M $913M -38.99%
New Positions 56 32 +24
Increased Positions 69 53 +16
Closed Positions 27 19 +8
Reduced Positions 52 49 +3
Total Calls 4 3 33.33%
Total Puts 2 1 100.0%
PUT/CALL Ratio 0.5 0.33 Bullish

Statistics: IRWD

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

197 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in IRWD. Verified SEC 13F-HR filings.

Top 25 institutional holders of IRWD — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 CM Management, LLC 1.03% 350,000 $1.2M
2 Range Financial Group LLC 0.51% 433,256 $1.5M
3 Inspire Investing, LLC 0.15% 509,941 $1.8M
4 Optimist Retirement Group LLC 0.15% 94,831 $333K
5 GSA CAPITAL PARTNERS LLP 0.14% 654,445 $2K
6 Hillsdale Investment Management Inc. 0.12% 1,236,628 $4.3M
7 SmartHarvest Portfolios, LLC 0.11% 75,462 $265K
8 WEDGE CAPITAL MANAGEMENT L L P/NC 0.04% 540,492 $1.9M
9 MQS Management LLC 0.03% 11,451 $40K
10 waypoint wealth counsel 0.02% 11,999 $42K
11 FEDERATED HERMES, INC. 0.02% 3,348,806 $11.8M
12 Connor, Clark & Lunn Investment Management Ltd. 0.01% 1,835,424 $6.4M
13 PROFUND ADVISORS LLC 0.01% 97,281 $341K
14 Broderick Brian C 0.01% 18,000 $63K
15 Pallas Capital Advisors LLC 0.01% 80,567 $283K
16 Abel Hall, LLC 0.01% 12,908 $45K
17 DGS Capital Management, LLC 0.01% 14,883 $52K
18 Stonebrook Private Inc. 0.01% 10,926 $38K
19 China Universal Asset Management Co., Ltd. 0.01% 28,936 $102K
20 Allegiance Financial Group Advisory Services LLC 0.01% 10,717 $38K
21 LOS ANGELES CAPITAL MANAGEMENT LLC 0.01% 509,247 $1.8M
22 WEDBUSH SECURITIES INC 0.01% 60,703 —
23 UBS Group AG 0.01% 11,200,320 $39.3M
24 Abacus Wealth Partners, LLC 0.01% 17,531 $62K
25 RITHOLTZ WEALTH MANAGEMENT 0.01% 87,535 $307K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — IRONWOOD PHARMACEUTICALS INC (IRWD)

What does the Smart Money Trend signal show for IRWD?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added IRWD than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for IRWD?

More buyers than sellers — 62% buying: Last quarter: 121 funds were net buyers (56 opened a brand new position + 65 added to an existing one). Only 74 were sellers (47 trimmed + 27 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for IRWD holders?

Elite ownership — 40% AUM from top-100 funds: 32 of 191 holders are among the 100 largest funds by AUM, controlling 40% of total institutional value in IRWD. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held IRWD?

59% of holders stayed for 2+ years: 112 out of 191 hedge funds have held IRWD for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.